Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
Medtronic PLC ha un obiettivo di prezzo di consenso pari a $98.42, stabilito in base alle ultime valutazioni degli analisti di 21. Le ultime 3 valutazioni degli analisti sono state rilasciate da Argus Research, Citigroup y Truist Securities il agosto 26, 2025, agosto 21, 2025 y agosto 21, 2025. Con un obiettivo di prezzo medio di $104 tra le Argus Research, Citigroup y Truist Securities, c'è un implicito 13.10% upside per Medtronic PLC da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
Argus Research
Citigroup
Truist Securities
Wells Fargo
UBS
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Medtronic
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
08/26/2025 | 25.07% | Argus Research | $105 → $115 | Maintains | Buy | |||
08/21/2025 | 9.84% | Citigroup | $99 → $101 | Maintains | Buy | |||
08/21/2025 | 4.4% | Truist Securities | $92 → $96 | Maintains | Hold | |||
08/20/2025 | 8.75% | Wells Fargo | $98 → $100 | Maintains | Overweight | |||
08/20/2025 | 3.32% | UBS | $94 → $95 | Maintains | Neutral | |||
08/20/2025 | 4.4% | Baird | $94 → $96 | Maintains | Neutral | |||
08/20/2025 | 6.58% | Bernstein | $97 → $98 | Maintains | Outperform | |||
08/14/2025 | — | Needham | — | Reiterates | Hold → Hold | |||
07/16/2025 | 8.75% | Mizuho | $98 → $100 | Maintains | Outperform | |||
07/15/2025 | 16.37% | Morgan Stanley | $98 → $107 | Maintains | Overweight | |||
07/09/2025 | 7.67% | Citigroup | $98 → $99 | Maintains | Buy | |||
07/08/2025 | 15.28% | Evercore ISI Group | $103 → $106 | Maintains | Outperform | |||
06/30/2025 | — | Wolfe Research | — | Upgrade | Underperform → Peer Perform | |||
06/16/2025 | 19.63% | Leerink Partners | → $110 | Initiates | → Outperform | |||
06/06/2025 | — | Needham | — | Reiterates | Hold → Hold | |||
05/22/2025 | 6.58% | Mizuho | $100 → $98 | Maintains | Outperform | |||
05/22/2025 | 9.84% | RBC Capital | $105 → $101 | Maintains | Outperform | |||
05/22/2025 | 0.05% | Baird | $94 → $92 | Maintains | Neutral | |||
05/22/2025 | — | Needham | — | Reiterates | Hold → Hold | |||
05/19/2025 | — | Needham | — | Reiterates | Hold → Hold | |||
04/11/2025 | -2.12% | Truist Securities | $93 → $90 | Maintains | Hold | |||
04/10/2025 | 2.23% | Baird | $91 → $94 | Maintains | Neutral | |||
03/04/2025 | 16.37% | Citigroup | $92 → $107 | Upgrade | Neutral → Buy | |||
02/19/2025 | — | Needham | — | Reiterates | Hold → Hold | |||
02/19/2025 | 14.19% | RBC Capital | $105 → $105 | Reiterates | Outperform → Outperform | |||
02/19/2025 | 3.32% | UBS | $85 → $95 | Maintains | Neutral | |||
02/19/2025 | -1.03% | Baird | $90 → $91 | Maintains | Neutral | |||
02/12/2025 | — | Needham | — | Reiterates | Hold → Hold | |||
01/06/2025 | -7.56% | UBS | $93 → $85 | Maintains | Neutral | |||
12/18/2024 | -3.21% | Truist Securities | $93 → $89 | Maintains | Hold | |||
12/17/2024 | 8.75% | Mizuho | $98 → $100 | Maintains | Outperform | |||
11/26/2024 | 18.54% | Barclays | $105 → $109 | Maintains | Overweight | |||
11/20/2024 | 5.49% | Bernstein | $96 → $97 | Maintains | Outperform | |||
11/20/2024 | 6.58% | Wells Fargo | $106 → $98 | Maintains | Overweight | |||
11/20/2024 | 1.14% | Baird | $96 → $93 | Maintains | Neutral | |||
11/20/2024 | — | Needham | — | Reiterates | → Hold | |||
11/19/2024 | 1.14% | UBS | $90 → $93 | Maintains | Neutral | |||
11/18/2024 | — | Needham | — | Reiterates | → Hold | |||
10/25/2024 | — | Needham | — | Reiterates | → Hold | |||
10/14/2024 | 1.14% | Truist Securities | $90 → $93 | Maintains | Hold | |||
10/10/2024 | 14.19% | RBC Capital | $98 → $105 | Upgrade | Sector Perform → Outperform | |||
10/08/2024 | 6.58% | RBC Capital | $92 → $98 | Maintains | Sector Perform | |||
10/01/2024 | 13.1% | Evercore ISI Group | $100 → $104 | Maintains | Outperform | |||
10/01/2024 | 0.05% | Citigroup | $85 → $92 | Maintains | Neutral | |||
08/23/2024 | -2.12% | Truist Securities | $85 → $90 | Maintains | Hold | |||
08/22/2024 | 14.19% | Barclays | $104 → $105 | Maintains | Overweight | |||
08/21/2024 | 2.23% | Oppenheimer | $92 → $94 | Maintains | Perform | |||
08/21/2024 | -2.12% | Piper Sandler | $85 → $90 | Maintains | Neutral | |||
08/21/2024 | 0.05% | RBC Capital | $92 → $92 | Reiterates | Sector Perform → Sector Perform | |||
08/21/2024 | 15.28% | Wells Fargo | $105 → $106 | Maintains | Overweight | |||
08/21/2024 | -2.12% | Baird | $82 → $90 | Maintains | Neutral | |||
08/21/2024 | -5.38% | Stifel | $85 → $87 | Maintains | Hold | |||
08/20/2024 | — | Needham | — | Reiterates | → Hold | |||
08/15/2024 | -2.12% | UBS | $76 → $90 | Upgrade | Sell → Neutral | |||
08/14/2024 | -7.56% | Stifel | $100 → $85 | Downgrade | Buy → Hold | |||
08/12/2024 | — | Needham | — | Reiterates | → Hold | |||
07/17/2024 | 0.05% | RBC Capital | $92 → $92 | Reiterates | Sector Perform → Sector Perform | |||
07/16/2024 | -7.56% | Truist Securities | $88 → $85 | Maintains | Hold | |||
07/10/2024 | -7.56% | Citigroup | $90 → $85 | Maintains | Neutral | |||
06/05/2024 | 0.05% | RBC Capital | $92 → $92 | Reiterates | Sector Perform → Sector Perform | |||
05/30/2024 | -9.73% | Goldman Sachs | → $83 | Initiates | → Sell | |||
05/24/2024 | 0.05% | RBC Capital | $92 → $92 | Reiterates | Sector Perform → Sector Perform | |||
05/24/2024 | 14.19% | Wells Fargo | $102 → $105 | Maintains | Overweight | |||
05/24/2024 | -17.35% | UBS | $75 → $76 | Maintains | Sell | |||
05/24/2024 | -4.3% | Truist Securities | $90 → $88 | Maintains | Hold | |||
05/24/2024 | — | Needham | — | Reiterates | → Hold | |||
02/21/2024 | 0.05% | RBC Capital | $92 → $92 | Reiterates | Sector Perform → Sector Perform | |||
02/21/2024 | 0.05% | Oppenheimer | $89 → $92 | Maintains | Perform | |||
02/21/2024 | 6.58% | Mizuho | $95 → $98 | Maintains | Buy | |||
02/21/2024 | -2.12% | Truist Securities | $87 → $90 | Maintains | Hold | |||
01/12/2024 | 0.05% | RBC Capital | $82 → $92 | Maintains | Sector Perform | |||
12/22/2023 | -5.38% | Truist Securities | $84 → $87 | Maintains | Hold | |||
11/22/2023 | -10.82% | RBC Capital | → $82 | Reiterates | Sector Perform → Sector Perform | |||
11/22/2023 | 6.58% | Morgan Stanley | $104 → $98 | Maintains | Overweight | |||
08/23/2023 | -3.21% | RBC Capital | → $89 | Reiterates | Sector Perform → Sector Perform | |||
08/23/2023 | -3.21% | Oppenheimer | → $89 | Reiterates | Perform → Perform | |||
08/23/2023 | -10.82% | UBS | $79 → $82 | Maintains | Sell | |||
08/23/2023 | 8.75% | Mizuho | $95 → $100 | Maintains | Buy | |||
08/23/2023 | 10.93% | Wells Fargo | $100 → $102 | Maintains | Overweight | |||
08/23/2023 | 3.32% | Stifel | $92 → $95 | Maintains | Buy | |||
07/19/2023 | -2.12% | Baird | → $90 | Initiates | → Neutral | |||
06/30/2023 | 15.28% | CL King | → $106 | Initiates | → Buy | |||
05/26/2023 | -3.21% | RBC Capital | → $89 | Reiterates | Sector Perform → Sector Perform | |||
05/26/2023 | -2.12% | Truist Securities | $93 → $90 | Maintains | Hold | |||
05/26/2023 | 0.05% | Stifel | $90 → $92 | Maintains | Buy | |||
05/26/2023 | 7.67% | Bernstein | $100 → $99 | Maintains | Outperform | |||
05/25/2023 | 8.75% | Evercore ISI Group | $88 → $100 | Maintains | Outperform | |||
04/24/2023 | 1.14% | Truist Securities | $88 → $93 | Maintains | Hold | |||
04/24/2023 | 13.1% | Barclays | $89 → $104 | Upgrade | Equal-Weight → Overweight | |||
04/24/2023 | 8.75% | Wells Fargo | $77 → $100 | Upgrade | Equal-Weight → Overweight | |||
04/21/2023 | -3.21% | RBC Capital | → $89 | Reiterates | → Sector Perform | |||
04/17/2023 | -4.3% | Truist Securities | $90 → $88 | Maintains | Hold | |||
01/24/2023 | 3.32% | Mizuho | $100 → $95 | Maintains | Buy | |||
01/09/2023 | -3.21% | RBC Capital | $102 → $89 | Downgrade | Outperform → Sector Perform | |||
11/30/2022 | -16.26% | Wells Fargo | $82 → $77 | Maintains | Equal-Weight | |||
11/25/2022 | -7.56% | Barclays | $90 → $85 | Maintains | Equal-Weight | |||
11/23/2022 | 10.93% | RBC Capital | $110 → $102 | Maintains | Outperform | |||
11/23/2022 | -7.56% | Oppenheimer | $106 → $85 | Downgrade | Outperform → Perform | |||
11/23/2022 | -4.3% | Morgan Stanley | $97 → $88 | Maintains | Equal-Weight | |||
11/23/2022 | -7.56% | Citigroup | $108 → $85 | Downgrade | Buy → Neutral |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Medtronic (MDT)?
El último precio objetivo de Medtronic (NYSE:MDT) fue comunicado por Argus Research el agosto 26, 2025. La firma de analistas fijó un precio objetivo para $115.00 que espera MDT a rise dentro de 12 meses (un posible 25.07% upside). 44 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Medtronic (MDT)?
La última calificación de analistas para Medtronic (NYSE:MDT) fue proporcionada por Argus Research, y Medtronic mantuvo su buy calificación.
¿Cuándo se produjo la última revisión al alza de Medtronic (MDT)?
La última revisión al alza de Medtronic PLC se produjo en junio 30, 2025, cuando Wolfe Research elevó su precio objetivo a N/A. Wolfe Research anteriormente tenía an underperform para Medtronic PLC.
¿Cuándo fue la última revisión a la baja de Medtronic (MDT)?
La última revisión a la baja de Medtronic PLC se produjo en agosto 14, 2024, cuando Stifel cambió su precio objetivo de $100 a $85 para Medtronic PLC.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Medtronic (MDT)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Medtronic, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Medtronic se registró el agosto 26, 2025, por lo que la próxima calificación estará disponible en torno al agosto 26, 2026.
¿Es correcta la calificación de los analistas sobre Medtronic (MDT)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Medtronic (MDT) fue un mantuvo con un precio objetivo de $105.00 a $115.00. El precio actual al que cotiza Medtronic (MDT) es de $91.95, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.